Cargando…

A Patient-Derived Xenograft Model of Parameningeal Embryonal Rhabdomyosarcoma for Preclinical Studies

Embryonal rhabdomyosarcoma (eRMS) is one of the most common soft tissue sarcomas in children and adolescents. Parameningeal eRMS is a variant that is often more difficult to treat than eRMS occurring at other sites. A 14-year-old female with persistent headaches and rapid weight loss was diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hooper, Jody E., Cantor, Emma L., Ehlen, Macgregor S., Banerjee, Avirup, Malempati, Suman, Stenzel, Peter, Woltjer, Randy L., Gandour-Edwards, Regina, Goodwin, Neal C., Yang, Yan, Kaur, Pali, Bult, Carol J., Airhart, Susan D., Keller, Charles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677247/ https://www.ncbi.nlm.nih.gov/pubmed/26696773 http://dx.doi.org/10.1155/2015/826124

Ejemplares similares

The impact of radiotherapy on clinical outcomes in parameningeal rhabdomyosarcoma
por: Choi, Yunseon, et al.
Publicado: (2016)

Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and Adolescents
por: Choi, Paul J, et al.
Publicado: (2018)

Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2019)

A rare presentation of a bilateral intracranial parameningeal embryonal rhabdomyosarcoma mimicking vestibular schwannoma in a two-year-old child: a case report
por: Salloum, Nadia Liber, et al.
Publicado: (2022)

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
por: Malcolm, Joan E., et al.
Publicado: (2019)

A Dosimetric Comparison of Intensity-Modulated Proton Therapy, Volumetric-Modulated Arc Therapy, and 4π Non-Coplanar Intensity-Modulated Radiation Therapy for a Patient with Parameningeal Rhabdomyosarcoma
por: Chen, Tiffany W, et al.
Publicado: (2017)

A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer
por: Woo, Xing Yi, et al.
Publicado: (2022)

Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
por: Bharathy, Narendra, et al.
Publicado: (2017)

EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017)

Novel Patient Metastatic Pleural Effusion-Derived Xenograft Model of Renal Medullary Carcinoma Demonstrates Therapeutic Efficacy of Sunitinib
por: Lee, Alex Q., et al.
Publicado: (2021)

In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma
por: Shoji, Chika, et al.
Publicado: (2023)

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy
por: Pan, Chong-xian, et al.
Publicado: (2015)

Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma
por: Wu, Jerry T., et al.
Publicado: (2023)

Physeal Bystander Effects in Rhabdomyosarcoma Radiotherapy: Experiments in a New Xenograft Model
por: Horton, Jason A., et al.
Publicado: (2011)

Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model
por: Abraham, Jinu, et al.
Publicado: (2011)

Patient-derived xenografts as preclinical neuroblastoma models
por: Braekeveldt, Noémie, et al.
Publicado: (2017)

Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
por: Woo, Xing Yi, et al.
Publicado: (2019)

Functional impact of a germline RET mutation in alveolar rhabdomyosarcoma
por: Berlow, Noah E., et al.
Publicado: (2021)

MiR-214 and N-ras regulatory loop suppresses rhabdomyosarcoma cell growth and xenograft tumorigenesis
por: Huang, Hui-jie, et al.
Publicado: (2014)

Establishment of 6 pediatric rhabdomyosarcoma patient’s derived xenograft models closely recapitulating patients’ tumor characteristics
por: Gasparini, Patrizia, et al.
Publicado: (2022)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016)

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
por: Kikuchi, Ken, et al.
Publicado: (2013)

Curcumin-Artemisinin Coamorphous Solid: Xenograft Model Preclinical Study
por: Mannava, M. K. Chaitanya, et al.
Publicado: (2018)

PATIENT-DERIVED XENOGRAFTS AS A PRECLINICAL MODEL FOR BONE SARCOMAS
por: MEOHAS, WALTER, et al.
Publicado: (2018)

Generation of Glioblastoma Patient-Derived Intracranial Xenografts for Preclinical Studies
por: Kerstetter-Fogle, Amber E., et al.
Publicado: (2020)

Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study
por: Cramer, Stuart L., et al.
Publicado: (2018)

Preclinical development of a chimeric antigen receptor T cell therapy targeting FGFR4 in rhabdomyosarcoma
por: Tian, Meijie, et al.
Publicado: (2023)

Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
por: Jung, Joohee
Publicado: (2014)

Patient-derived xenografts: a relevant preclinical model for drug development
por: Pompili, Luca, et al.
Publicado: (2016)

Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies
por: Heo, Eun Jin, et al.
Publicado: (2017)

Patient-derived xenografts: a promising resource for preclinical cancer research
por: Karamboulas, Christina, et al.
Publicado: (2019)

Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies
por: William, Doreen, et al.
Publicado: (2017)

The Role of PDGFR-β Activation in Acquired Resistance to IGF-1R Blockade in Preclinical Models of Rhabdomyosarcoma()
por: Heske, Christine M., et al.
Publicado: (2016)

Temozolomide combined with irinotecan caused regression in an adult pleomorphic rhabdomyosarcoma patient-derived orthotopic xenograft (PDOX) nude-mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2017)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
por: Jäger, Wolfgang, et al.
Publicado: (2015)

Circadian rhythm impacts preclinical FDG-PET quantification in the brain, but not in xenograft tumors
por: Krueger, Marcel A., et al.
Publicado: (2020)

A Preclinical Embryonic Zebrafish Xenograft Model to Investigate CAR T Cells in Vivo
por: Pascoal, Susana, et al.
Publicado: (2020)

Preclinical Testing of CAR T Cells in a Patient-Derived Xenograft Model of Glioblastoma
por: Tatari, Nazanin, et al.
Publicado: (2020)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
por: Kleinmanns, Katrin, et al.
Publicado: (2022)

Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug Evaluation
por: Serra-Camprubí, Queralt, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_upekbhebid33et03v8tu1eu3l1